Rapidemic is a developer of diagnostic kits for infectious diseases.
Rapidemic has raised $3.1M in total funding. The most recent round was Grant. The last funding was announced in September 2025.
Rapidemic's investors include Bill & Melinda Gates Foundation, Graduate Ventures, BioInnovation Institute.
Rapidemic is headquartered in Leiden, The Netherlands.
Rapidemic is a developer of diagnostic kits for infectious diseases.
Rapidemic is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rapidemic — Funding & Investors." VCBacked, September 25, 2025, https://www.vcbacked.co/company/rapidemic. Accessed September 30, 2026.
VCBacked. (2025). Rapidemic — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/rapidemic
{{cite web |title=Rapidemic — Funding & Investors |url=https://www.vcbacked.co/company/rapidemic |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated